Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kevin Markey
Observed names:
K Markey,
K. Markey,
Kevin M. Markey
Institution:
Medicines and Healthcare products Regulatory Agency
Observed institutions:
University of Liverpool,
Institute of Technology Tallaght,
Health Protection Agency,
Medicines and Healthcare products Regulatory Agency,
National Institute for Biological Standards and Control
ORCID:
0000-0003-0390-5182
Observed ORCID:
0000-0003-0390-5182
OpenAlex ID:
A5048864266
Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015
2019
·
Alex-Mikael Barkoff
, Jussi Mertsola
, et al.
·
Eurosurveillance
·
114
PDF
Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015
2018
·
Alex-Mikael Barkoff
, Jussi Mertsola
, et al.
·
Journal of Clinical Microbiology
·
55
PDF
Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells
2007
·
T. Mullen
, K. Markey
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
·
40
Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assays
2014
·
Dorothy Xing
, Kevin Markey
, et al.
·
Expert Review of Vaccines
·
26
Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
2019
·
Kevin Markey
, Catpagavalli Asokanathan
, et al.
·
Toxins
·
24
PDF
EUVAC.NET collaborative study: Evaluation and standardisation of serology for diagnosis of pertussis
2011
·
Dorothy Xing
, Kevin Markey
, et al.
·
Journal of Immunological Methods
·
24
Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains
2010
·
Mei M. Ho
, Kevin Markey
, et al.
·
Vaccine
·
24
Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine
2010
·
Kevin Markey
, Mei M. Ho
, et al.
·
Vaccine
·
22
Improvement in serological diagnosis of pertussis by external quality assessment
2019
·
Kevin Markey
, Alex Douglas-Bardsley
, et al.
·
Journal of Medical Microbiology
·
20
Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine
2008
·
Mei M. Ho
, Kevin Markey
, et al.
·
Vaccine
·
20
A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines
2014
·
Alex-Mikael Barkoff
, Nicole Guiso
, et al.
·
Journal of Immunological Methods
·
19
Caenorhabditis elegans killing assay as an infection model to study the role of type III secretion in Burkholderia cenocepacia
2006
·
Kevin M. Markey
, Kerry J. Glendinning
, et al.
·
Journal of Medical Microbiology
·
18
Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay.
2018
·
K Markey
, A Douglas-Bardsley
, et al.
·
PubMed
·
15
Differences in epitope‐specific antibodies to pertussis toxin after infection and acellular vaccinations
2020
·
Aapo Knuutila
, Tine Dalby
, et al.
·
Clinical & Translational Immunology
·
14
PDF
In search of acceptable alternatives to the murine histamine sensitisation test (HIST): what is possible and practical?
2016
·
L Wagner
, R Isbrucker
, et al.
·
PubMed
·
10
An ELISA method to estimate the mono ADP-ribosyltransferase activities: e.g in pertussis toxin and vaccines
2017
·
Catpagavalli Asokanathan
, Sharon Tierney
, et al.
·
Analytical Biochemistry
·
8
Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III
2011
·
Lorna Lancaster
, Manolya Saydam
, et al.
·
Vaccine
·
8
Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine
2014
·
Masaki Ochiai
, Yoshinobu Horiuchi
, et al.
·
Human Vaccines & Immunotherapeutics
·
7
PDF
Quantitative bead–based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples
2025
·
Vishal Rathod
, Sagar Katke
, et al.
·
Frontiers in Immunology
·
4
PDF
Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines
2023
·
Cerissa van Walstijn
, Stefan Verweij
, et al.
·
Vaccine
·
4
Development of an in vitro Biochemical Assay System for the Measurement of Residual Toxin Activities in Pertussis Toxin Containing Vaccines
2017
·
Chun Ting Yuen
, Catpagavalli Asokanathan
, et al.
·
Journal of Vaccines & Vaccination
·
3
PDF
Collaborative study for the calibration of the replacement International Standard for pertussis toxin for use in histamine sensitisation and CHO cell clustering assays
2019
·
Alexandra Douglas-Bardsley
, Catpagavalli Asokanathan
, et al.
·
Biologicals
·
2
PDF
External quality assurance scheme for Bordetella pertussis serology : On behalf of EUpert-labnet network
2013
·
Norman K. Fry
, Kevin Markey
, et al.
·
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
·
2
An assessment of thermal stability ofClostridium difficiletoxoid formulations
2011
·
Lorna E. Lancaster
, Kevin Markey
, et al.
·
Human Vaccines
·
2
PDF
Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigen induces partial protection in a mouse model
2025
·
Alexa Dierig
, Martina Kristof
, et al.
·
Vaccine X
·
1
Show more works
View as search
Works count:
29
Citation count:
489
H-index:
14
I10-index:
15
Year
Topic
Type